Stay updated on Eftilagimod Combo with Pembrolizumab in HNSCC Clinical Trial
Sign up to get notified when there's something new on the Eftilagimod Combo with Pembrolizumab in HNSCC Clinical Trial page.

Latest updates to the Eftilagimod Combo with Pembrolizumab in HNSCC Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedRevision: v3.3.3 was added and HHS Vulnerability Disclosure and Revision: v3.3.2 were removed from the page footer. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check24 days agoChange DetectedOutcome Measures, Study Status, and Recruitment Status were added to the record history, and the previous 'Active, not recruiting' status was removed, with a new 'Completed' status recorded on 2025-12-11.SummaryDifference0.6%

- Check38 days agoChange DetectedThe history now shows Revision: v3.3.2 and removal of Revision: v3.3.1, an administrative update to the version history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check45 days agoChange DetectedRevision entries were updated: added v3.3.1 and removed v3.2.0 from the history.SummaryDifference0.1%

- Check53 days agoChange DetectedThe notice about government funding and potential data delays was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check67 days agoChange DetectedVersion 23 (2025-06-25) was added, updating Study Status, Eligibility, Arms and Interventions, and Outcome Measures in the study record. This addition indicates ongoing updates to the trial's registration information.SummaryDifference0.1%

Stay in the know with updates to Eftilagimod Combo with Pembrolizumab in HNSCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Eftilagimod Combo with Pembrolizumab in HNSCC Clinical Trial page.